Moexipril Hydrochloride
NDC 0093-0017, Moexipril Hydrochloride, tablet, film coated, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-0017
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-0017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOEXIPRIL HYDROCHLORIDE7.5 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-0017-01 | 00093001701 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5d4078f3-b621-475f-a4e6-005de2e62b32NADAC price for package 00093001701
GET /v1/drugs/nadac/00093001701
Use it
Look up 0093-0017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-0017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-0017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.